PT - JOURNAL ARTICLE AU - David Margolius AU - Mary Hennekes AU - Jimmy Yao AU - Douglas Einstadter AU - Douglas Gunzler AU - Nabil Chehade AU - Ashwini R. Sehgal AU - Yasir Tarabichi AU - Adam T. Perzynski TI - On the Front (Phone) Lines: Results of a COVID-19 Hotline in Northeast Ohio AID - 10.1101/2020.05.08.20095745 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.08.20095745 4099 - http://medrxiv.org/content/early/2020/05/13/2020.05.08.20095745.short 4100 - http://medrxiv.org/content/early/2020/05/13/2020.05.08.20095745.full AB - Importance Severe acute respiratory syndrome coronavirus (SARS-CoV-2) and the associated coronavirus disease of 2019 (COVID-19) have presented immense challenges for health care systems. Many regions have struggled to adapt to disruptions to health care practice and employ systems that effectively manage the demand for services.Objective To examine the effectiveness of the first five weeks’ of a 24/7 physician-staffed COVID-19 hotline.Design Cohort study using electronic health records.Setting A single large health care system in Northeast Ohio.Participants During 5 weeks of operation, 10,112 patients called the hotline (callers) and were evaluated by a registered nurse (RN) using standardized protocols. Of these, 4,213 (42%) were referred for a physician telehealth visit (telehealth patients). The mean age of callers was 42 years. 67% were female, 51% white, and 46% were on Medicaid or uninsured.Intervention Physician telehealth visits for COVID-19.Main Outcomes and Measures We describe clinical diagnosis, patient characteristics (age, sex race/ethnicity, smoking status, insurance status), and visit disposition. We use logistic regression to evaluate associations between patient characteristics, visit disposition and subsequent emergency department use, hospitalization, and SARS-Cov-2 PCR testing.Results Common caller concerns included cough, fever, and shortness of breath. Most telehealth patients (79%) were advised to self-isolate at home, 14% were determined to be unlikely to have COVID-19, 3% were advised to seek emergency care, and 4% had miscellaneous other dispositions. A total of 287 (7%) patients had a subsequent ED visit, and 44 (1%) were hospitalized with a COVID-19 diagnosis. Of the callers, 482 (5%) had a COVID-19 test reported with 69 (14%) testing positive. Among patients advised to stay at home, 83% had no further face-to-face visits. In multivariable results, only a physician recommendation to seek emergency care was associated with emergency room use (OR=4.73, 95%CI 1.37-16.39, p=.014). Only older age was associated with having a positive test result.Conclusions and Relevance Robust, physician-directed telehealth services can meet a wide range of needs during the acute phase of a pandemic, conserving scarce resources such as personal protective equipment and testing supplies and preventing the spread of infections to patients and health care workers.Question What is the feasibility and effectiveness of physician telehealth services during a pandemic?Findings In this cohort study of a COVID-19 telehealth hotline that included 10,112 callers and 4,213 physician telehealth visits, most patients (79%) were advised to self-isolate at home, 14% were found unlikely to have COVID-19, 4% dispositions (e.g. testing or office visit) and 3% were advised to immediately seek care emergency department. 83% of patients who were advised to stay home did not require in-person visits.Meaning Physician-directed telehealth services conserve scarce resources and provide effective, equitable care during a pandemic without compromising patient safety.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the MetroHealth System. No external funding was involved.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data can be requested directly from the authors.